Literature DB >> 25704480

Proliferative role of TRAF4 in breast cancer by upregulating PRMT5 nuclear expression.

Fan Yang1, Jian Wang, Hua-Yan Ren, Juan Jin, Ai-Lian Wang, Li-Li Sun, Ke-Xin Diao, En-Hua Wang, Xiao-Yi Mi.   

Abstract

In this study, we examined protein arginine methyltransferase 5 (PRMT5) and tumor necrosis factor receptor-associated 4 (TRAF4) expression in breast cancer to find the interaction mechanism between the two. We examined TRAF4 and PRMT5 expression by immunohistochemistry and found that their expression is positively correlated in breast cancer. Besides, PRMT5 expression was significantly associated with histological type and tumor size (p < 0.05). PRMT5 nuclear expression was significantly associated with HER2 expression (p < 0.05). PRMT5 and TRAF4 were both overexpressed in breast cancer tissues and cells, and we found that PRMT5 binds to the zinc finger structures in TRAF4 by coimmunoprecipitation and Western blotting. We also tested the potential regulatory effect between TRAF4 and PRMT5. TRAF4 upregulated PRMT5 expression, which occurred predominantly in the nucleus, on which TRAF4 promotion of cell proliferation in breast cancer is mainly dependent. PRMT5 may play an important role in activation of the NF-κB signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25704480     DOI: 10.1007/s13277-015-3262-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  30 in total

1.  Role for Traf4 in polarizing adherens junctions as a prerequisite for efficient cell shape changes.

Authors:  Sam J Mathew; Martina Rembold; Maria Leptin
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

2.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

3.  PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB.

Authors:  Han Wei; Benlian Wang; Masaru Miyagi; Yun She; Banu Gopalan; De-Bin Huang; Gourisankar Ghosh; George R Stark; Tao Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-31       Impact factor: 11.205

4.  Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials.

Authors:  Michael F Press; Guido Sauter; Leslie Bernstein; Ivonne E Villalobos; Martina Mirlacher; Jian-Yuan Zhou; Rooba Wardeh; Yong-Tian Li; Roberta Guzman; Yanling Ma; Jane Sullivan-Halley; Angela Santiago; Jinha M Park; Alessandro Riva; Dennis J Slamon
Journal:  Clin Cancer Res       Date:  2005-09-15       Impact factor: 12.531

5.  Methylation of ribosomal protein S10 by protein-arginine methyltransferase 5 regulates ribosome biogenesis.

Authors:  Jinqi Ren; Yaqing Wang; Yuheng Liang; Yongqing Zhang; Shilai Bao; Zhiheng Xu
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

Review 6.  Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.

Authors:  Debajit K Biswas; J Dirk Iglehart
Journal:  J Cell Physiol       Date:  2006-12       Impact factor: 6.384

7.  Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-beta signaling that affects neural crest formation.

Authors:  Tuzer Kalkan; Yasuno Iwasaki; Chong Yon Park; Gerald H Thomsen
Journal:  Mol Biol Cell       Date:  2009-05-20       Impact factor: 4.138

8.  PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation.

Authors:  Hiroshi Tanaka; Yutaka Hoshikawa; Tomoko Oh-hara; Sumie Koike; Mikihiko Naito; Tetsuo Noda; Hiroyuki Arai; Takashi Tsuruo; Naoya Fujita
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

Review 9.  All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction.

Authors:  Jee Y Chung; Young Chul Park; Hong Ye; Hao Wu
Journal:  J Cell Sci       Date:  2002-02-15       Impact factor: 5.285

10.  Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors.

Authors:  Dawid Eckert; Katharina Biermann; Daniel Nettersheim; Ad J M Gillis; Klaus Steger; Hans-Martin Jäck; Annette M Müller; Leendert H J Looijenga; Hubert Schorle
Journal:  BMC Dev Biol       Date:  2008-11-07       Impact factor: 1.978

View more
  16 in total

1.  Novel interaction of antioxidant-1 with TRAF4: role in inflammatory responses in endothelial cells.

Authors:  Archita Das; Varadarajan Sudhahar; Masuko Ushio-Fukai; Tohru Fukai
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-25       Impact factor: 4.249

2.  LKB1 regulates PRMT5 activity in breast cancer.

Authors:  Hanine Lattouf; Loay Kassem; Julien Jacquemetton; Ali Choucair; Coralie Poulard; Olivier Trédan; Laura Corbo; Mona Diab-Assaf; Nader Hussein; Isabelle Treilleux; Muriel Le Romancer
Journal:  Int J Cancer       Date:  2018-10-31       Impact factor: 7.396

Review 3.  Protein arginine methyltransferases: promising targets for cancer therapy.

Authors:  Jee Won Hwang; Yena Cho; Gyu-Un Bae; Su-Nam Kim; Yong Kee Kim
Journal:  Exp Mol Med       Date:  2021-05-18       Impact factor: 8.718

4.  PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression.

Authors:  Kelly Chiang; Agnieszka E Zielinska; Abeer M Shaaban; Maria Pilar Sanchez-Bailon; James Jarrold; Thomas L Clarke; Jingxian Zhang; Adele Francis; Louise J Jones; Sally Smith; Olena Barbash; Ernesto Guccione; Gillian Farnie; Matthew J Smalley; Clare C Davies
Journal:  Cell Rep       Date:  2017-12-19       Impact factor: 9.423

5.  Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status.

Authors:  Bhavna Kumar; Arti Yadav; Nicole V Brown; Songzhu Zhao; Michael J Cipolla; Paul E Wakely; Alessandra C Schmitt; Robert A Baiocchi; Theodoros N Teknos; Matthew Old; Pawan Kumar
Journal:  Oncotarget       Date:  2017-02-28

Review 6.  Protein arginine methylation/demethylation and cancer.

Authors:  Coralie Poulard; Laura Corbo; Muriel Le Romancer
Journal:  Oncotarget       Date:  2016-10-11

7.  Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers.

Authors:  Mathilde Vinet; Samyuktha Suresh; Virginie Maire; Clarisse Monchecourt; Fariba Némati; Laetitia Lesage; Fabienne Pierre; Mengliang Ye; Auriane Lescure; Amélie Brisson; Didier Meseure; André Nicolas; Guillem Rigaill; Elisabetta Marangoni; Elaine Del Nery; Sergio Roman-Roman; Thierry Dubois
Journal:  Cancer Med       Date:  2019-04-08       Impact factor: 4.452

8.  PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways.

Authors:  Shuyu Mei; Shuang Ge; Jun Wang; Hailing Li; Xiaotong Jing; Ke Liang; Xiaoying Zhang; Chaoshuai Xue; Cuijuan Zhang; Tingguo Zhang
Journal:  J Pathol Clin Res       Date:  2021-01-08

9.  TRAF4 Regulates Migration, Invasion, and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma.

Authors:  Kairui Liu; Xiaolin Wu; Xian Zang; Zejian Huang; Zeyu Lin; Wenliang Tan; Xiang Wu; Wenrou Hu; Baoqi Li; Lei Zhang
Journal:  Oncol Res       Date:  2017-03-02       Impact factor: 5.574

10.  Low expression of PRMT5 in peripheral blood may serve as a potential independent risk factor in assessments of the risk of stable CAD and AMI.

Authors:  Buchuan Tan; Qian Liu; Liping Yang; Yushuang Yang; Dongna Liu; Long Liu; Fanbo Meng
Journal:  BMC Cardiovasc Disord       Date:  2019-01-31       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.